You are here: Welcome » Maria Gutschi

Maria Gutschi

Dr. L. Maria Gutschi, PharmD is a Canadian pharmacist based in Ontario, Canada.

History

COVID-19

On October 29, 2022, the Canadian Covid Care Alliance (CCCA) published a paper authored by Gutschi on the manufacturing and quality issues underlying the BNT162b2 COVID-19 vaccine product by Pfizer-BioNTech.1)

The analysis was based on the Public Assessment Report prepared by the European Medicines Agency (EMA), as part of a 900+ page document dump hosted on Covid Truths.2)

Gutschi's co-authors include David Speicher, Susan Natsheh, Phil Oldfield, Philip Britz-McKibbon, Michael Palmer, Neil Karrow, Bernard Massie, Bonnie Mallard, Glenn Chan and Steven Pelech.

A video presentation of the investigation was also published to BitChute and the CCCA website.3) 4)

1)
Gutschi, L. M., Speicher, D. J., Natsheh, S., Oldfield, P., Britz-Mckibbon, P., Palmer, M., Karrow, N., Massie, B., Mallard, B., Chan, G., & Pelech, S. (2022). An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR). Canadian Covid Care Alliance. https://web.archive.org/web/20221110200231/https://www.canadiancovidcarealliance.org/wp-content/uploads/2022/11/22OC29_EMA-Analysis-of-BNT162b-Manufacture.pdf
3)
DRWR2021. (2022, November 2). Quality issues with mRNA Covid vaccine production. BitChute. https://archive.ph/kPCL0
4)
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Vaccine (Video). Canadian Covid Care Alliance. Retrieved November 9, 2022, from https://web.archive.org/web/20221109043439/https://www.canadiancovidcarealliance.org/media-resources/an-independent-analysis-of-the-manufacturing-and-quality-issues-of-the-bnt162b-biontech-pfizer-vaccine-video/
Back to top